NCM·Healthcare·$342M·#180 / 520 in Healthcare
VSTM Verastem, Inc.
55SPECULATIVE
CATEGORY BREAKDOWN
GROWTH100
QUALITY60
STABILITY43
VALUATION60
GOVERNANCE5
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+209.1%
100
> 50% strong
Gross Margin
Revenue retained after direct costs
82.9%
100
> 50% strong
Cash Runway
Months of cash at current burn rate
18 months
65
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
152.4%
0
< 25% strong
Price / Sales
Market cap relative to trailing revenue
6.9x
60
< 3x strong
Rule of 40
Growth rate plus operating margin
-341
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
0.9%
7
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+42.8%
0
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE VSTM WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when VSTM's score changes by 5+ points.
DATA INFO
Last updated: Jul 1, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.